Molecular subtyping drives confident treatment decisions for breast cancer

Human Breast Cancer Molecular Subtyping Quantitative Detection Kit(PCR-Fluorophore-labeling Probes)

China NMPA certified | CE Certified

Non-invasive, Instant, Home-based and Self-testing

Prediction and Screening of Pre-eclampsia in the 2nd and 3rd Trimester of Prenancy.

China NMPA certified | CE Certified

Latest News

Low Risk Patients Identified by MammaTyper® LRP Had Significantly Better DDFS and Did Not Benefit from Adjuvant Chemotherapy BERLIN, GERMANY, December 15, 2025 | Cerca Biotech., a Germany-based diagnostics company, announces the poster presentation at San Antonio Breast Cancer Symposium 2025 of a study highlighting the […]
The results from a prospective clinical study on CercaTest RED™ was presented in the Asia Pacific Congress in Maternal Fetal Medicine 2025 (APCMFM) held from November 1 to 3 in Osaka, Japan. The Asia-Pacific Congress of Maternal-Fetal Medicine (APCMFM) is one of the most influential academic […]
BERLIN, GERMANY, October 27, 2025 — Cerca Biotech., a German-based diagnostics company, announces the publication of a white paper highlighting the importance of molecular diagnostics in HER2-low breast cancer cases as a potential to improve the diagnostic complexity. MammaTyper® is a molecular diagnostic test from Cerca Biotech, a reverse transcription, […]

Screening, diagnosis & precision medicine for women’s health.

We are committed to becoming a global leader in innovative diagnosis and precision medicine focused on women’s health.

Precision Medicine for Breast Cancer

Precision Medicine for Oncology

Maternal Fetal Diagnostics & Health

Reproductive Tract Infection & Health

R&D Center
Diagnostics for Maternal Fetal Medicine
Marketing and Sales
IVD Products Manufacturing
Central Laboratory Services
Production and Marketing Center for Global Market

Every women deserves better diagnosis and precision medicine

Precision diagnostic products or services covering breast health, maternal fetal medicine, reproductive tract infections, tumor detection, and family health management.